Methods and compositions for the treatment of proliferative disorders
作者： Kun Ping Lu , Xiao Zhen Zhou , Shuo Wei
DOI:
关键词:
摘要: The invention features methods of treating a proliferative disorder characterized by elevated Pin1 marker levels and/or reduced Ser71 phosphorylation in subject administering retinoic acid compound. Additionally, the disorders (e.g., levels) compound combination with another anti-proliferative Finally, also including high-throughput screens for discovering and validating inhibitors.
lens.org 参考文章(43)
Rajan Pragani, Kun Ping Lu, Mindy Irene Emily Davis, Xiao Zhen Zhou, Shuo Wei, Matthew Brian Boxer, Anton Momtchilov Simeonov, Min Shen, Methods and compositions for the inhibition of Pin1 ,(2013)
Kun Ping Lu, Tony Hunter, NIMA interacting proteins ,(2003)
Janusz Sowadski, Robert K. Suto, Methods for designing specific inhibitors for Pin1 proline isomerase and Pin1-related molecules ,(2003)
Lewis C. Cantley, Kun Ping Lu, Michael Yaffee, Gunter Fischer, Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases ,(1998)
Kun Ping Lu, Xiao Zhen Zhou, Methods and compositions for regulating protein-protein interactions ,(2000)
Shmuel A. Ben-Sasson, Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent ,(2007)
Peter Davies, Karen Duff, Transgenic mice comprising a genomic human tau transgene ,(2003)
Kun Ping Lu, Xiao Zhen Zhou, Methods and compositions for the generation and use of conformation-specific antibodies ,(2014)
Li Feng, Peng Huang, William Plunkett, Cancer therapeutics involving the administration of 2-methoxyestradiol and an agent that increases intracellular superoxide anion ,(2001)